Treating cat allergy with monoclonal IgG antibodies that bind allergen and prevent IgE engagement

Features and development of Coot

Emsley, P., Lohkamp, B., Scott, W. G., & Cowtan, K. D. (2010) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444910007493 · Cited by 27,510 · see citing works

<i>Phaser</i> crystallographic software

McCoy, A. J., Grosse-Kunstleve, R. W., Adams, P. D., Winn, M. D., Storoni, L. C., & Read, R. J. (2007) · Journal of Applied Crystallography · doi:10.1107/s0021889807021206 · Cited by 20,612 · see citing works

Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis

Simpson, E. L., Bieber, T., Guttman-Yassky, E., Beck, L. A., Blauvelt, A., Cork, M. J., Silverberg, J. I., Deleuran, M., Kataoka, Y., Lacour, J.-P., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1610020 · Cited by 2,110 · see citing works

Dupilumab Treatment in Adults with Moderate-to-Severe Atopic Dermatitis

Beck, L. A., Thaçi, D., Hamilton, J. D., Graham, N. M. H., Bieber, T. R. M., Rocklin, R. E., Ming, J. E., Ren, H., Kao, R., Simpson, E. L., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1314768 · Cited by 1,415 · see citing works

Long-Term Clinical Efficacy of Grass-Pollen Immunotherapy

Durham, S. R., Walker, S. M., Varga, E., Jacobson, M. R., O'Brien, F., Noble, W. J., Till, S. J., Hamid, Q. A., & Nouri‐Aria, K. T. (1999) · New England Journal of Medicine · doi:10.1056/nejm199908123410702 · Cited by 1,371 · see citing works

PROPHYLACTIC INOCULATION AGAINST HAY FEVER

Noon, L. (1911) · The Lancet · doi:10.1016/s0140-6736(00)78276-6 · Cited by 1,343 · see citing works

Integrated signalling pathways for mast-cell activation

Gilfillan, A. M., & Tkaczyk, C. (2006) · Nature reviews. Immunology · doi:10.1038/nri1782 · Cited by 955 · see citing works

Dupilumab efficacy and safety in adults with uncontrolled persistent asthma despite use of medium-to-high-dose inhaled corticosteroids plus a long-acting β2 agonist: a randomised double-blind placebo-controlled pivotal phase 2b dose-ranging trial

Wenzel, S. E., Castro, M., Corren, J., Maspero, J. F., Wang, L., Zhang, B., Pirozzi, G., Sutherland, E. R., Evans, R. R., Joish, V. N., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)30307-5 · Cited by 886 · see citing works

Effect of Subcutaneous Dupilumab on Nasal Polyp Burden in Patients With Chronic Sinusitis and Nasal Polyposis: A Randomized Clinical Trial

Bachert, C., Mannent, L., Naclerio, R. M., Mullol, J., Ferguson, B. J., Gevaert, P., Hellings, P., Jiao, L., Wang, L., Evans, R. R., et al. (2016) · JAMA · doi:10.1001/jama.2015.19330 · Cited by 794 · see citing works

Clinical efficacy and immune regulation with peanut oral immunotherapy

Jones, S. M., Pons, L., Roberts, J. L., Scurlock, A. M., Perry, T. T., Kulis, M., Shreffler, W. G., Steele, P. H., Henry, K. A., Adair, M., et al. (2009) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2009.05.022 · Cited by 718 · see citing works

SQ-standardized sublingual grass immunotherapy: Confirmation of disease modification 2 years after 3 years of treatment in a randomized trial

Durham, S. R., Emminger, W., Kapp, A., de Monchy, J. G. R., Rak, S., Scadding, G. K., Würtzen, P. A., Andersen, J. S., Tholstrup, B., Riis, B., et al. (2012) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2011.12.973 · Cited by 516 · see citing works

Dupilumab improves the molecular signature in skin of patients with moderate-to-severe atopic dermatitis

Hamilton, J. D., Suárez‐Fariñas, M., Dhingra, N., Cardinale, I. R., Li, X., Kostić, A., Ming, J. E., Radin, A. R., Krueger, J. G., Graham, N. M. H., et al. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.10.013 · Cited by 472 · see citing works

Mice with megabase humanization of their immunoglobulin genes generate antibodies as efficiently as normal mice

Murphy, A. J., Macdonald, L. E., Stevens, S. G., Karow, M. L., Dore, A. T., Pobursky, K. J., Huang, T. T., Poueymirou, W. T., Esau, L., Meola, M., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1324022111 · Cited by 454 · see citing works

Effect of Avoidance on Peanut Allergy after Early Peanut Consumption

Toit, G. D., Sayre, P. H., Roberts, G. C., Sever, M. L., Lawson, K., Bahnson, H. T., Brough, H. A., Santos, A. F., Harris, K. M., Radulović, S., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1514209 · Cited by 411 · see citing works

Precise and in situ genetic humanization of 6 Mb of mouse immunoglobulin genes

Macdonald, L. E., Karow, M. L., Stevens, S. G., Auerbach, W., Poueymirou, W. T., Yasenchak, J., Frendewey, D. A., Valenzuela, D. M., Giallourakis, C. C., Alt, F. W., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1323896111 · Cited by 390 · see citing works

Effect of Omalizumab on Symptoms of Seasonal Allergic Rhinitis&lt;SUBTITLE&gt;A Randomized Controlled Trial&lt;/SUBTITLE&gt;

Casale, T. B. (2001) · JAMA · doi:10.1001/jama.286.23.2956 · Cited by 377 · see citing works

Long-term tolerance after allergen immunotherapy is accompanied by selective persistence of blocking antibodies

James, L. K., Shamji, M. H., Walker, S. M., Wilson, D. R., Wachholz, P. A., Francis, J. N., Jacobson, M. R., Kimber, I., Till, S. J., & Durham, S. R. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.12.1080 · Cited by 338 · see citing works

Grass pollen immunotherapy: IL-10 induction and suppression of late responses precedes IgG4 inhibitory antibody activity

Francis, J. N., James, L. K., Paraskevopoulos, G., Wong, C., Calderón, M. A., Durham, S. R., & Till, S. J. (2008) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2008.01.072 · Cited by 328 · see citing works

Immunological changes during specific immunotherapy of grass pollen allergy: reduced lymphoproliferative responses to allergen and shift from TH2 to TH1 in T‐cell clones specific for Phi p 1, a major grass pollen allergen

Ebner, C., Siemann, U., Bohle, B., Willheim, M., Wiedermann, U., Schenk, S., KLOTZ, F., Ebner, H., Kraft, D., & Scheiner, O. (1997) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.1997.tb01252.x · Cited by 328 · see citing works

Epitope-specific T cell tolerance to phospholipase A2 in bee venom immunotherapy and recovery by IL-2 and IL-15 in vitro.

Akdiş, C. A., Akdiş, M., Blesken, T., Wymann, D., Alkan, Ş. Ş., Müller, U., & Blaser, K. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118963 · Cited by 312 · see citing works

Functional rather than immunoreactive levels of IgG4 correlate closely with clinical response to grass pollen immunotherapy

Shamji, M. H., Ljørring, C., Francis, J. N., Calderón, M. A., Larché, M., Kimber, I., Frew, A. J., Ipsen, H., Lund, K., Würtzen, P. A., et al. (2011) · Allergy · doi:10.1111/j.1398-9995.2011.02745.x · Cited by 295 · see citing works

Isolation and partial characterization of the major allergen from Japanese cedar (Cryptomeria japonica) pollen

Yasueda, H., Yui, Y., Shimizu, T., & Shida, T. (1983) · Journal of Allergy and Clinical Immunology · doi:10.1016/0091-6749(83)90550-x · Cited by 265 · see citing works

Effect of 2 Years of Treatment With Sublingual Grass Pollen Immunotherapy on Nasal Response to Allergen Challenge at 3 Years Among Patients With Moderate to Severe Seasonal Allergic Rhinitis: The GRASS Randomized Clinical Trial

Scadding, G. W., Calderon, M. A., Shamji, M. H., Eifan, A. O., Penagos, M., Dumitru, F., Sever, M. L., Bahnson, H. T., Lawson, K., Harris, K. M., et al. (2017) · JAMA · doi:10.1001/jama.2016.21040 · Cited by 229 · see citing works

Mechanisms of immunotherapy: IgG revisited

Wachholz, P. A., & Durham, S. R. (2004) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/01.all.0000136753.35948.c0 · Cited by 198 · see citing works

Fel d 1–derived peptide antigen desensitization shows a persistent treatment effect 1 year after the start of dosing: A randomized, placebo-controlled study

Patel, D., Couroux, P., Hickey, P., Salapatek, A. M., Laidler, P., Larché, M., & Hafner, R. P. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2012.07.028 · Cited by 198 · see citing works

A chimeric human-cat fusion protein blocks cat-induced allergy

Zhu, D., Kepley, C. L., Zhang, K., Terada, T., Yamada, T., & Saxon, A. (2005) · Nature Medicine · doi:10.1038/nm1219 · Cited by 188 · see citing works

Vaccine development for allergen-specific immunotherapy based on recombinant allergens and synthetic allergen peptides: Lessons from the past and novel mechanisms of action for the future

Valenta, R., Campana, R., Focke-Tejkl, M., & Niederberger, V. (2016) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2015.12.1299 · Cited by 181 · see citing works

Development and preliminary clinical evaluation of a peptide immunotherapy vaccine for cat allergy

Worm, M., Lee, H., Kleine‐Tebbe, J., Hafner, R. P., Laidler, P., Healey, D., Buhot, C., Verhoef, A., Maillère, B., Kay, A. B., et al. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.11.029 · Cited by 170 · see citing works

Recombinant Marker Allergens: Diagnostic Gatekeepers for the Treatment of Allergy

Kazemi-Shirazi, L., Niederberger, V., Linhart, B., Lidholm, J., Kraft, D., & Valenta, R. (2002) · International Archives of Allergy and Immunology · doi:10.1159/000057742 · Cited by 164 · see citing works

Renaissance of the Blocking Antibody Concept in Type I Allergy

Flicker, S., & Valenta, R. (2003) · International Archives of Allergy and Immunology · doi:10.1159/000073260 · Cited by 162 · see citing works

T Cell Epitope Immunotherapy Induces a CD4+ T Cell Population with Regulatory Activity

Verhoef, A., Alexander, C. E., Kay, A. B., & Larché, M. (2005) · PLoS Medicine · doi:10.1371/journal.pmed.0020078 · Cited by 160 · see citing works

The IgE-facilitated allergen binding (FAB) assay: Validation of a novel flow-cytometric based method for the detection of inhibitory antibody responses

Shamji, M. H., Wilcock, L. K., Wachholz, P. A., Dearman, R. J., Kimber, I., Würtzen, P. A., Larché, M., Durham, S. R., & Francis, J. N. (2006) · Journal of Immunological Methods · doi:10.1016/j.jim.2006.09.004 · Cited by 149 · see citing works

Dose dependence and time course of the immunologic response to administration of standardized cat allergen extract

Nanda, A., O'Connor, M., Anand, M. K., Dreskin, S. C., Zhang, L., Hines, B. T., Lane, D., Wheat, W. H., Routes, J. M., Sawyer, R. T., et al. (2004) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2004.08.049 · Cited by 143 · see citing works

Development and characterization of a recombinant, hypoallergenic, peptide-based vaccine for grass pollen allergy

Focke‐Tejkl, M., Weber, M., Niespodziana, K., Neubauer, A., Huber, H., Henning, R., Stegfellner, G., Maderegger, B., Hauer, M., Stolz, F., et al. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.09.012 · Cited by 139 · see citing works

Successful immunotherapy induces previously unidentified allergen-specific CD4+ T-cell subsets

Ryan, J. F., Hovde, R., Glanville, J., Lyu, S., Ji, X., Gupta, S., Tibshirani, R. J., Jay, D. C., Boyd, S. D., Chinthrajah, R. S., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1520180113 · Cited by 138 · see citing works

Mechanisms, safety and efficacy of a B cell epitope-based vaccine for immunotherapy of grass pollen allergy

Zieglmayer, P., Focke-Tejkl, M., Schmutz, R., Lemell, P., Zieglmayer, R., Weber, M., Kiss, R., Blatt, K., Valent, P., Stolz, F., et al. (2016) · EBioMedicine · doi:10.1016/j.ebiom.2016.08.022 · Cited by 138 · see citing works

Synthetic antibodies for specific recognition and crystallization of structured RNA

Ye, J., Tereshko, V. A., Frederiksen, J. K., Koide, A., Fellouse, F. A., Sidhu, S. S., Koide, S., Kossiakoff, A. A., & Piccirilli, J. A. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709082105 · Cited by 134 · see citing works

Mediators of inflammation in the early and the late phase of allergic rhinitis

Hansen, I., Klimek, L., Mösges, R., & Hörmann, K. (2004) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/00130832-200406000-00004 · Cited by 126 · see citing works

The crystal structure of the major cat allergen Fel d 1, a member of the secretoglobin family

Kaiser, L., Grönlund, H., Sandalova, T., Ljunggren, H.-G., van Hage-Hamsten, M., Achour, A., & Schneider, G. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m304740200 · Cited by 122 · see citing works

Effects of omalizumab on basophil and mast cell responses using an intranasal cat allergen challenge

Eckman, J. A., Sterba, P. M., Kelly, D., Alexander, V., Liu, M. C., Bochner, B. S., MacGlashan, D. W., & Saini, S. S. (2009) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2009.09.012 · Cited by 117 · see citing works

Fel d 1‐derived synthetic peptide immuno‐regulatory epitopes show a long‐term treatment effect in cat allergic subjects

Couroux, P. R., Patel, D. B., Armstrong, K., Larché, M., & Hafner, R. P. (2015) · Clinical & Experimental Allergy · doi:10.1111/cea.12488 · Cited by 108 · see citing works

Flow cytometry for basophil activation markers: The measurement of CD203c up-regulation is as reliable as CD63 expression in the diagnosis of cat allergy

Ocmant, A., Peignois, Y., Mulier, S., Hanssens, L., Michils, A., & Schandené, L. (2007) · Journal of Immunological Methods · doi:10.1016/j.jim.2006.12.002 · Cited by 107 · see citing works

A hypoallergenic cat vaccine based on Fel d 1–derived peptides fused to hepatitis B PreS

Niespodziana, K., Focke‐Tejkl, M., Linhart, B., Civaj, V., Blatt, K., Valent, P., van Hage, M., Grönlund, H., & Valenta, R. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2011.02.004 · Cited by 104 · see citing works

A double-blind, placebo-controlled immunotherapy dose-response study with standardized cat extract

Ewbank, P. A., Murray, J., Sanders, K., Curran‐Everett, D., Dreskin, S. C., & Nelson, H. S. (2003) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2003.41 · Cited by 103 · see citing works

Anti-IgE (omalizumab) inhibits late-phase reactions and inflammatory cells after repeat skin allergen challenge

Ong, Y. E., Menzies-Gow, A. N., Barkans, J. R., Benyahia, F., Ou, T.-T., Sun, Y., & Kay, A. B. (2005) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2005.05.035 · Cited by 97 · see citing works

Allergen skin tests and free IgE levels during reduction and cessation of omalizumab therapy

Corren, J., Shapiro, G., Reimann, J., Deniz, Y., Wong, D., Adelman, D., & Togias, A. (2008) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2007.11.026 · Cited by 83 · see citing works

Treatment effect of sublingual immunotherapy tablets and pharmacotherapies for seasonal and perennial allergic rhinitis: Pooled analyses

Durham, S. R., Creticos, P. S., Nelson, H. S., Li, Z., Kaur, A., Meltzer, E. O., & Nolte, H. (2016) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2016.04.061 · Cited by 82 · see citing works

Simultaneous exposure of several allergens has an additive effect on multisensitized basophils

Nopp, A., Johansson, S. G. O., Lundberg, M., & Öman, H. (2006) · Allergy · doi:10.1111/j.1398-9995.2006.01211.x · Cited by 79 · see citing works

Fluticasone furoate nasal spray reduces the nasal-ocular reflex: A mechanism for the efficacy of topical steroids in controlling allergic eye symptoms

Baroody, F. M., Shenaq, D., deTineo, M., Wang, J., & Naclerio, R. M. (2009) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2009.03.015 · Cited by 77 · see citing works

Efficacy of 2 months of allergen-specific immunotherapy with Bet v 1–derived contiguous overlapping peptides in patients with allergic rhinoconjunctivitis: Results of a phase IIb study

Spertini, F., DellaCorte, G., Kettner, A., Frederic de, B. L. A. Y., Jacobsen, L., Jutel, M., Worm, M., Charlon, V., & Reymond, C. (2016) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2016.02.044 · Cited by 69 · see citing works

An essential role for RasGRP1 in mast cell function and IgE-mediated allergic response

Liu, Y., Zhu, M., Nishida, K., Hirano, T., & Zhang, W. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20061598 · Cited by 65 · see citing works

IgG-mediated down-regulation of IgE bound to mast cells: a potential novel mechanism of allergen-specific desensitization

Uermösi, C., Zabel, F., Manolova, V., Bauer, M., Beerli, R. R., Senti, G., Kündig, T. M., Saudan, P., & Bachmann, M. F. (2013) · Allergy · doi:10.1111/all.12327 · Cited by 64 · see citing works

T Cell Epitope Peptide Therapy for Allergic Diseases

O’Hehir, R. E., Prickett, S. R., & Rolland, J. M. (2016) · Current Allergy and Asthma Reports · doi:10.1007/s11882-015-0587-0 · Cited by 64 · see citing works

The effects of an anti–IL-13 mAb on cytokine levels and nasal symptoms following nasal allergen challenge

Nicholson, G. C., Kariyawasam, H. H., Tan, A. J., Hohlfeld, J. M., Quinn, D. A., Walker, C., Rodman, D. M., Westwick, J. K., Jurčević, S., Kon, O. M., et al. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2011.05.013 · Cited by 63 · see citing works

A long-term follow-up study of hyposensitization with immunoblotting

Jensen‐Jarolim, E., Poulsen, L. K., Stadler, B. M., Mosbech, H., ØSterballe, O., Kraft, D., & Weeke, B. (1990) · Journal of Allergy and Clinical Immunology · doi:10.1016/0091-6749(90)90043-4 · Cited by 62 · see citing works

When allergies complicate allergies

Wickman, M. C. (2005) · Allergy · doi:10.1111/j.1398-9995.2005.00852.x · Cited by 51 · see citing works

T Cell Epitope-Based Allergy Vaccines

Larché, M. (2011) · Current topics in microbiology and immunology · doi:10.1007/82_2011_131 · Cited by 50 · see citing works

Passive immunization with allergen-specific IgG antibodies for treatment and prevention of allergy

Flicker, S., Linhart, B., Wild, C., Wiedermann, U., & Valenta, R. (2012) · Immunobiology · doi:10.1016/j.imbio.2012.10.008 · Cited by 46 · see citing works

Local and systemic effects of cat allergen nasal provocation

Scadding, G. W., Eifan, A. O., Penagos, M., Dumitru, A., Switzer, A., McMahon, O., Phippard, D., Togias, A. G., Durham, S. R., & Shamji, M. H. (2014) · Clinical & Experimental Allergy · doi:10.1111/cea.12434 · Cited by 43 · see citing works

Hypoallergenic derivatives of Fel d 1 obtained by rational reassembly for allergy vaccination and tolerance induction

Curin, M., Weber, M., Thalhamer, T., Swoboda, I., Focke‐Tejkl, M., Blatt, K., Valent, P., Marth, K., Garmatiuk, T., Grönlund, H., et al. (2014) · Clinical & Experimental Allergy · doi:10.1111/cea.12294 · Cited by 36 · see citing works

Role of the Major Allergen (Fel d I) in Patients Sensitized to Cat Allergens

Kleine‐Tebbe, J., Kleine-Tebbe, A., Jeep, S., Schou, C., Løwenstein, H., & Kunkel, G. (2009) · International Archives of Allergy and Immunology · doi:10.1159/000236421 · Cited by 36 · see citing works

Flexible IgE epitope-containing domains of Phl p 5 cause high allergenic activity

Göbl, C., Focke‐Tejkl, M., Najafi, N., Schrank, E., Madl, T., Kosol, S., Madritsch, C., Dorofeeva, Y., Flicker, S., Thalhamer, J., et al. (2017) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2017.05.005 · Cited by 31 · see citing works

Enlarging the repertoire of therapeutic monoclonal antibodies platforms: domesticating half molecule exchange to produce stable IgG4 and IgG1 bispecific antibodies

Yang, X., & Ambrogelly, A. (2014) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2014.09.001 · Cited by 30 · see citing works

Passive Immunization with Allergen-Specific Antibodies

Flicker, S., Gadermaier, E., Madritsch, C., & Valenta, R. (2011) · Current topics in microbiology and immunology · doi:10.1007/82_2011_143 · Cited by 22 · see citing works

Onset and duration of action of levocabastine nasal spray in atopic patients under nasal challenge conditions

Corren, J., Rachelefsky, G. S., Spector, S. L., Schanker, H. M., Siegel, S. C., Holton, D., Karcher, K., & Travers, S. (1999) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(99)70226-5 · Cited by 18 · see citing works

Cat allergen-induced blood basophil reactivity in vitro predicts acute human nasal allergen challenge responses in vivo

Paterniti, M. O., Kelly, D., Eckman, J. A., Sterba, P. M., Hamilton, R. G., Bochner, B. S., MacGlashan, D. W., & Saini, S. S. (2011) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2011.03719.x · Cited by 10 · see citing works

An integrated analysis of the efficacy of fluticasone furoate nasal spray versus placebo on the nasal symptoms of perennial allergic rhinitis

Wu, W., Walters, R. D., Nadeau, G. A., Botnick, W. C., & Broughton, N. (2013) · Allergy and Asthma Proceedings · doi:10.2500/aap.2013.34.3662 · Cited by 5 · see citing works

Title Page

(2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(11)00170-9 · Cited by 1 · see citing works

Allergen immunotherapy: past, present and future

Durham, S. R., & Shamji, M. H. (2022) · Nature reviews. Immunology · doi:10.1038/s41577-022-00786-1 · Cited by 426 · see citing works

The role of allergen‐specific IgE, IgG and IgA in allergic disease

Shamji, M. H., Valenta, R., Jardetzky, T. S., Verhasselt, V., Durham, S. R., Würtzen, P. A., & van Neerven, R. J. J. (2021) · Allergy · doi:10.1111/all.14908 · Cited by 339 · see citing works

EAACI Molecular Allergology User's Guide 2.0

Dramburg, S., Hilger, C., Santos, A. F., Vecillas, L. D. L., Aalberse, R. C., Acevedo, N., Aglas, L., Altmann, F., Arruda, L. K., Asero, R., et al. (2023) · Pediatric Allergy and Immunology · doi:10.1111/pai.13854 · Cited by 332 · see citing works

High-affinity allergen-specific human antibodies cloned from single IgE B cell transcriptomes

Croote, D., Darmanis, S., Nadeau, K. C., & Quake, S. R. (2018) · Science · doi:10.1126/science.aau2599 · Cited by 223 · see citing works

IgE and IgG Antibodies as Regulators of Mast Cell and Basophil Functions in Food Allergy

Kanagaratham, C., Ansari, Y. S. E., Lewis, O. L., & Oettgen, H. C. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.603050 · Cited by 208 · see citing works

Mechanisms of allergen-specific immunotherapy

Głobińska, A., Boonpiyathad, T., Satitsuksanoa, P., Kleuskens, M. T. A., van de Veen, W., Sokołowska, M., & Akdiş, M. (2018) · Annals of Allergy Asthma & Immunology · doi:10.1016/j.anai.2018.06.026 · Cited by 133 · see citing works

Allergen Extracts for In Vivo Diagnosis and Treatment of Allergy: Is There a Future?

Valenta, R., Karaulov, A., Niederberger, V., Zhernov, Y., Elisyutina, O., Campana, R., Focke-Tejkl, M., Curin, M., Namazova-Baranova, L., Wang, J.-Y., et al. (2018) · Journal of Allergy and Clinical Immunology: In Practice · doi:10.1016/j.jaip.2018.08.032 · Cited by 115 · see citing works

Past, present, and future of allergen immunotherapy vaccines

Dorofeeva, Y., Shilovskiy, I. P., Tulaeva, I., Focke‐Tejkl, M., Flicker, S., Kudlay, D. A., Khaitov, M. R., Васильевна, К. А., Riabova, K. A., Karaulov, A. V., et al. (2020) · Allergy · doi:10.1111/all.14300 · Cited by 127 · see citing works

A broadly protective antibody that targets the flavivirus NS1 protein

Modhiran, N., Song, H., Liu, L., Bletchly, C., Brillault, L., Amarilla, A. A., Xu, X., Qi, J., Chai, Y., Cheung, S. T. M., et al. (2021) · Science · doi:10.1126/science.abb9425 · Cited by 126 · see citing works

Guideline on allergen immunotherapy in IgE-mediated allergic diseases

Pfaar, O., Ankermann, T., Augustin, M., Bubel, P., Böing, S., Brehler, R., Eng, P. A., Fischer, P. J., Gerstlauer, M., Hamelmann, E. H., et al. (2022) · Allergologie select · doi:10.5414/alx02331e · Cited by 124 · see citing works

IgE Antibodies: From Structure to Function and Clinical Translation

Sutton, B. J., Davies, A. M., Bax, H. J., & Karagiannis, S. N. (2019) · Antibodies · doi:10.3390/antib8010019 · Cited by 121 · see citing works

Allergen Immunotherapy: Current and Future Trends

Pavón-Romero, G. F., Parra-Vargas, M. I., Jiménez, F. R., Melgoza-Ruiz, E., Serrano-Pérez, N. H., & Teran, L. M. (2022) · Cells · doi:10.3390/cells11020212 · Cited by 126 · see citing works

Recent developments and highlights in food allergy

Eiwegger, T., Hung, L., Diego, K. E. S., O’Mahony, L., & Upton, J. E. M. (2019) · Allergy · doi:10.1111/all.14082 · Cited by 111 · see citing works

Chronic allergen exposure drives accumulation of long-lived IgE plasma cells in the bone marrow, giving rise to serological memory

Asrat, S., Kaur, N., Liu, X., Ben, L., Kajimura, D., Murphy, A. J., Sleeman, M. A., Limnander, A., & Orengo, J. M. (2020) · Science Immunology · doi:10.1126/sciimmunol.aav8402 · Cited by 108 · see citing works

Vaccine against peanut allergy based on engineered virus-like particles displaying single major peanut allergens

Storni, F., Zeltiņš, A., Baļķe, I., Heath, M. D., Kramer, M. F., Skinner, M. A., Zha, L., Roesti, E. S., Engeroff, P., Muri, L., et al. (2019) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2019.12.007 · Cited by 107 · see citing works

Molecular profiling of allergen-specific antibody responses may enhance success of specific immunotherapy

Rodríguez-Domínguez, A., Berings, M., Rohrbach, A., Huang, H., Curin, M., Gevaert, P., Matricardi, P. M., Valenta, R., & Vrtala, S. (2020) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2020.03.029 · Cited by 86 · see citing works

One hundred and ten years of Allergen Immunotherapy: A journey from empiric observation to evidence

Pfaar, O., Bousquet, J., Durham, S. R., Kleine‐Tebbe, J., Larché, M., Roberts, G. C., Shamji, M. H., & van Wijk, R. G. (2021) · Allergy · doi:10.1111/all.15023 · Cited by 86 · see citing works

FcεRI: A Master Regulator of Mast Cell Functions

Nagata, Y., & Suzuki, R. (2022) · Cells · doi:10.3390/cells11040622 · Cited by 81 · see citing works

Novel antibody cocktail targeting Bet v 1 rapidly and sustainably treats birch allergy symptoms in a phase 1 study

Gevaert, P., Craemer, J. D., Ruyck, N. D., Rottey, S., Hoon, J. N. J. M. D., Hellings, P. W., Volckaert, B., Lesneuck, K., Orengo, J. M., Atanasio, A., et al. (2021) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2021.05.039 · Cited by 79 · see citing works

Keep the cat, change the care pathway: a transformational approach to managing Fel d 1, the major cat allergen

Satyaraj, E., Wedner, H. J., & Bousquet, J. (2019) · Allergy · doi:10.1111/all.14013 · Cited by 78 · see citing works

Recombinant allergens for immunotherapy: state of the art

Zhernov, Y. V., Curin, M., Khaitov, M. R., Karaulov, A. V., & Valenta, R. (2019) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/aci.0000000000000536 · Cited by 77 · see citing works

Allergen immunotherapy for long-term tolerance and prevention

Penagos, M., & Durham, S. R. (2022) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2022.01.007 · Cited by 81 · see citing works

Mechanisms of human drug-induced anaphylaxis

Bruhns, P., & Chollet‐Martin, S. (2021) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2021.02.013 · Cited by 76 · see citing works

Passive Prophylactic Administration with a Single Dose of Anti–Fel d 1 Monoclonal Antibodies REGN1908–1909 in Cat Allergen–induced Allergic Rhinitis: A Randomized, Double-Blind, Placebo-controlled Clinical Trial

Shamji, M. H., Singh, I., Layhadi, J. A., Ito, C., Karamani, A., Kouser, L., Sharif, H., Tang, J., Handijiev, S., Parkin, R. V., et al. (2021) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202011-4107oc · Cited by 74 · see citing works

Hot topics in allergen immunotherapy, 2023: Current status and future perspective

Zemelka‐Wiącek, M., Agache, I. O., Akdiş, C. A., Akdiş, M., Casale, T. B., Dramburg, S., Jahnz‐Różyk, K., Kosowska, A., Matricardi, P. M., Pfaar, O., et al. (2023) · Allergy · doi:10.1111/all.15945 · Cited by 73 · see citing works

New approaches to allergen immunotherapy

Gunawardana, N. C., & Durham, S. R. (2018) · Annals of Allergy Asthma & Immunology · doi:10.1016/j.anai.2018.07.014 · Cited by 72 · see citing works

New Mechanistic Advances in FcεRI-Mast Cell–Mediated Allergic Signaling

Li, Y., Leung, P. S. C., Gershwin, M. E., & Song, J. (2022) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-022-08955-9 · Cited by 72 · see citing works

Next-Generation of Allergen-Specific Immunotherapies: Molecular Approaches

Curin, M., Khaitov, M. R., Karaulov, A. V., Namazova-Baranova, L. S., Campana, R., Garib, V., & Valenta, R. (2018) · Current Allergy and Asthma Reports · doi:10.1007/s11882-018-0790-x · Cited by 68 · see citing works

Allergen-Specific Antibodies Regulate Secondary Allergen-Specific Immune Responses

Eckl‐Dorna, J., Villazala‐Merino, S., Linhart, B., Karaulov, A. V., Zhernov, Y. V., Khaitov, M. R., Niederberger‐Leppin, V., & Valenta, R. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2018.03131 · Cited by 66 · see citing works

Molecular Approaches for Diagnosis, Therapy and Prevention of Cow’s Milk Allergy

Linhart, B., Freidl, R., Elisyutina, O. G., Khaitov, M. R., Karaulov, A. V., & Valenta, R. (2019) · Nutrients · doi:10.3390/nu11071492 · Cited by 64 · see citing works

The use of biologics for immune modulation in allergic disease

van de Veen, W., & Akdiş, M. (2019) · Journal of Clinical Investigation · doi:10.1172/jci124607 · Cited by 63 · see citing works

Targeting immunodominant Bet v 1 epitopes with monoclonal antibodies prevents the birch allergic response

Atanasio, A., Franklin, M. C., Kamat, V., Hernandez, A. R., Badithe, A., Ben, L., Jones, J. L., Bautista, J., Yancopoulos, G. D., Olson, W. C., et al. (2021) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2021.05.038 · Cited by 58 · see citing works

The role of IgG1 and IgG4 as dominant IgE-blocking antibodies shifts during allergen immunotherapy

Strobl, M. R., Demir, H., Acosta, G. S., Drescher, A., Kitzmüller, C., Möbs, C., Pfützner, W., & Bohle, B. (2023) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2023.01.005 · Cited by 57 · see citing works

Immunotherapy-induced neutralizing antibodies disrupt allergen binding and sustain allergen tolerance in peanut allergy

LaHood, N. A., Min, J., Keswani, T., Richardson, C. M., Amoako, K., Zhou, J., Marini‐Rapoport, O., Bernard, H., Hazebrouck, S., Shreffler, W. G., et al. (2023) · Journal of Clinical Investigation · doi:10.1172/jci164501 · Cited by 54 · see citing works

Tolerance mechanisms in allergen immunotherapy

Sözener, Z. Ç., Mungan, D., Cevhertas, L., Öğülür, İ., Akdiş, M., & Akdiş, C. A. (2020) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/aci.0000000000000693 · Cited by 52 · see citing works

CpG Adjuvant in Allergen-Specific Immunotherapy: Finding the Sweet Spot for the Induction of Immune Tolerance

Montamat, G., Leonard, C., Poli, A., Klimek, L., & Ollert, M. W. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.590054 · Cited by 50 · see citing works

Mechanisms of allergen-specific immunotherapy for allergic rhinitis and food allergies

Lam, H. Y., Tergaonkar, V., & Ahn, K. S. (2020) · Bioscience Reports · doi:10.1042/bsr20200256 · Cited by 49 · see citing works

Structural Aspects of the Allergen-Antibody Interaction

Pomés, A., Mueller, G., & Chruszcz, M. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.02067 · Cited by 40 · see citing works

REGN1908/1909 prevented cat allergen–induced early asthmatic responses in an environmental exposure unit

Frederic de, B. L. A. Y., Gherasim, A., Domis, N., Meier, P., Shawki, F., Wang, C. Q. F., Orengo, J. M., DeVeaux, M., Ramesh, D., Jalbert, J. J., et al. (2022) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2022.06.025 · Cited by 43 · see citing works

Pathogenesis of IgE‐mediated food allergy and implications for future immunotherapeutics

Ramsey, N., & Berin, M. C. (2021) · Pediatric Allergy and Immunology · doi:10.1111/pai.13501 · Cited by 45 · see citing works

The origins of allergy from a systems approach

Krempski, J. W., Dant, C. C., & Nadeau, K. C. (2020) · Annals of Allergy Asthma & Immunology · doi:10.1016/j.anai.2020.07.013 · Cited by 41 · see citing works

Preventive Allergen-Specific Vaccination Against Allergy: Mission Possible?

Tulaeva, I., Kratzer, B., Campana, R., Curin, M., van Hage, M., Васильевна, К. А., Riabova, K. A., Karaulov, A. V., Khaitov, M. R., Pickl, W. F., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01368 · Cited by 40 · see citing works

One Hundred Ten Years of Allergen Immunotherapy: A Broad Look Into the Future

Pfaar, O., Creticos, P. S., Kleine‐Tebbe, J., Canonica, G. W., Palomares, Ó., & Schülke, S. (2021) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2020.12.067 · Cited by 40 · see citing works

Research advances in hydrogen–deuterium exchange mass spectrometry for protein epitope mapping

Sun, H., Ma, L., Wang, L., Xiao, P., Li, H., Zhou, M., & Song, D. (2021) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-020-03091-9 · Cited by 38 · see citing works

Immunization of Cats against Fel d 1 Results in Reduced Allergic Symptoms of Owners

Thoms, F., Haas, S., Erhart, A., Nett, C. S., Rüfenacht, S., Graf, N., Strods, A., Patil, G., Leenadevi, T., Fontaine, M. C., et al. (2020) · Viruses · doi:10.3390/v12030288 · Cited by 37 · see citing works

Vaccination against Allergy: A Paradigm Shift?

Bachmann, M. F., Mohsen, M. O., Kramer, M. F., & Heath, M. D. (2020) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2020.01.007 · Cited by 36 · see citing works

B cells: The many facets of B cells in allergic diseases

Satitsuksanoa, P., Iwasaki, S., Boersma, J., Imam, M. B., Schneider, S. R., Chang, I., van de Veen, W., & Akdiş, M. (2023) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2023.05.011 · Cited by 35 · see citing works

From Allergen Molecules to Molecular Immunotherapy of Nut Allergy: A Hard Nut to Crack

Fuhrmann, V., Huang, H., Akarsu, A., Shilovskiy, I. P., Elisyutina, O. G., Khaitov, M. R., van Hage, M., Linhart, B., Focke‐Tejkl, M., Valenta, R., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.742732 · Cited by 35 · see citing works

Differential modulation of allergic rhinitis nasal transcriptome by dupilumab and allergy immunotherapy

Wipperman, M. F., Gayvert, K. M., Atanasio, A., Wang, C. Q. F., Corren, J., Covarrubias, A., Setliff, I., Chio, E., Laws, E., Wolfe, K., et al. (2024) · Allergy · doi:10.1111/all.16001 · Cited by 34 · see citing works

The next generation virus‐like particle platform for the treatment of peanut allergy

Sobczak, J. M., Krenger, P. S., Storni, F., Mohsen, M. O., Baļķe, I., Resēviča, G., Heath, M. D., Velazquez, T. L. C., Kramer, M. F., Scott, C. J. W., et al. (2023) · Allergy · doi:10.1111/all.15704 · Cited by 33 · see citing works

Epitope Mapping by HDX-MS Elucidates the Surface Coverage of Antigens Associated with High Blocking Efficiency of Antibodies to Birch Pollen Allergen

Zhang, Q., Yang, J., Bautista, J., Badithe, A., Olson, W. C., & Liu, Y. (2018) · Analytical Chemistry · doi:10.1021/acs.analchem.8b01864 · Cited by 33 · see citing works

Broad IgG repertoire in patients with chronic rhinosinusitis with nasal polyps regulates proinflammatory IgE responses

Shamji, M. H., Thomsen, I., Layhadi, J. A., Kappen, J. H., Holtappels, G., Şahiner, Ü. M., Switzer, A., Durham, S. R., Pabst, O., & Bachert, C. (2019) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2019.02.001 · Cited by 32 · see citing works

A therapeutic strategy to target distinct sources of IgE and durably reverse allergy

Limnander, A., Kaur, N., Asrat, S., Tasker, C., Boyapati, A., Ben, L., Janczy, J. R., Pedraza, P. L., Abreu, P., Chen, W.-C., et al. (2023) · Science Translational Medicine · doi:10.1126/scitranslmed.adf9561 · Cited by 31 · see citing works

Evolutionary Biology and Gene Editing of Cat Allergen, Fel d 1

Brackett, N. F., Davis, B. W., Adli, M., Pomés, A., & Chapman, M. D. (2022) · The CRISPR Journal · doi:10.1089/crispr.2021.0101 · Cited by 31 · see citing works

Engineering therapeutic monoclonal antibodies

Stone, C. A., Spiller, B. W., & Smith, S. A. (2023) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2023.11.018 · Cited by 29 · see citing works

A Single Monoclonal Antibody against the Peanut Allergen Ara h 2 Protects against Systemic and Local Peanut Allergy

Storni, F., Cabral‐Miranda, G., Roesti, E. S., Zha, L., Engeroff, P., Zeltiņš, A., Cragg, M. S., Vogel, M., & Bachmann, M. F. (2020) · International Archives of Allergy and Immunology · doi:10.1159/000505917 · Cited by 29 · see citing works

Targeting Ara h 2 with human‐derived monoclonal antibodies prevents peanut‐induced anaphylaxis in mice

Paolucci, M., Wuillemin, N., Homère, V., Bieli, D., Köhli, A., Ballmer-Weber, B. K., Waeckerle‐Men, Y., Pengo, N., Kündig, T. M., Sonati, T., et al. (2023) · Allergy · doi:10.1111/all.15659 · Cited by 29 · see citing works

Targeting the FcεRI Pathway as a Potential Strategy to Prevent Food-Induced Anaphylaxis

Dispenza, M. C., Bochner, B. S., & MacGlashan, D. W. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.614402 · Cited by 28 · see citing works

The Multifaceted B Cell Response in Allergen Immunotherapy

Jiménez‐Saiz, R., & Patil, S. U. (2018) · Current Allergy and Asthma Reports · doi:10.1007/s11882-018-0819-1 · Cited by 28 · see citing works

Resistance of parvalbumin to gastrointestinal digestion is required for profound and long‐lasting prophylactic oral tolerance

Freidl, R., Gstöttner, A., Baranyi, U., Swoboda, I., Stolz, F., Focke‐Tejkl, M., Wekerle, T., van Ree, R., Valenta, R., & Linhart, B. (2019) · Allergy · doi:10.1111/all.13994 · Cited by 28 · see citing works

Allergen-specific IgE levels and the ability of IgE-allergen complexes to cross-link determine the extent of CD23-mediated T-cell activation

Villazala‐Merino, S., Rodríguez-Domínguez, A., Stanek, V., Campion, N. J., Gattinger, P., Höfer, G., Fröschl, R., Faé, I., Lupinek, C., Vrtala, S., et al. (2019) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2019.11.019 · Cited by 27 · see citing works

Mapping Human Monoclonal IgE Epitopes on the Major Dust Mite Allergen Der p 2

Mueller, G. A., Glesner, J., Daniel, J., Zhang, J., Hyduke, N., Richardson, C. M., DeRose, E. F., Chapman, M. D., Peebles, R. S., Smith, S. A., et al. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.2000295 · Cited by 27 · see citing works

A Human IgE Antibody Binding Site on Der p 2 for the Design of a Recombinant Allergen for Immunotherapy

Glesner, J., Kapingidza, A. B., Godzwon, M., Offermann, L. R., Mueller, G. A., DeRose, E. F., Wright, P., Richardson, C. M., Woodfolk, J. A., Vailes, L. D., et al. (2019) · The Journal of Immunology · doi:10.4049/jimmunol.1900580 · Cited by 26 · see citing works

On the role of allergen-specific IgG subclasses for blocking human basophil activation

Zinkhan, S., Thoms, F., Augusto, G. S., Vogel, M., & Bachmann, M. F. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.892631 · Cited by 26 · see citing works

Mechanisms and biomarkers of successful allergen-specific immunotherapy

López, J.-F., Imam, M. B., Satitsuksanoa, P., Lems, S., Yang, M., Hwang, Y.-K., Losol, P., Choi, J., Kim, S., Chang, Y., et al. (2022) · Asia Pacific Allergy · doi:10.5415/apallergy.2022.12.e45 · Cited by 26 · see citing works

Highlights of Novel Vaccination Strategies in Allergen Immunotherapy

Komlósi, Z. I., Kovács, N., Sokołowska, M., van de Veen, W., Akdiş, M., & Akdiş, C. A. (2019) · Immunology and Allergy Clinics of North America · doi:10.1016/j.iac.2019.09.010 · Cited by 26 · see citing works

Molecular approaches to allergen‐specific immunotherapy: Are we so far from clinical implementation?

Pechsrichuang, P., & Jacquet, A. (2020) · Clinical & Experimental Allergy · doi:10.1111/cea.13588 · Cited by 25 · see citing works

Targeting Mast Cells with Biologics

Lyons, J. J., & Metcalfe, D. D. (2020) · Immunology and Allergy Clinics of North America · doi:10.1016/j.iac.2020.06.007 · Cited by 27 · see citing works

Expression and epitope identification of myosin light chain isoform 1, an allergen in Procambarus clarkii

Yang, Y., Yan, H., Zhang, Y., Chen, H., Cao, M., Li, M., Zhang, M.-L., He, X., & Liu, G. (2020) · Food Chemistry · doi:10.1016/j.foodchem.2020.126422 · Cited by 23 · see citing works

Comprehensive mapping of immune tolerance yields a regulatory TNF receptor 2 signature in a murine model of successful Fel d 1‐specific immunotherapy using high‐dose CpG adjuvant

Leonard, C. A., Montamat, G., Davril, C., Domingues, O., Hunewald, O. E., Revets, D., Guérin, C. L., Blank, S., Heckendorn, J., Jardon, G., et al. (2020) · Allergy · doi:10.1111/all.14716 · Cited by 23 · see citing works

The combination of allergen immunotherapy and biologics for inhalant allergies: Exploring the synergy

Olivieri, B., Günaydın, F. E., Corren, J., Senna, G., & Durham, S. R. (2024) · Annals of Allergy Asthma & Immunology · doi:10.1016/j.anai.2024.06.016 · Cited by 22 · see citing works

Human allergy to cats: A review for veterinarians on prevalence, causes, symptoms and control

Sparkes, A. (2021) · Journal of Feline Medicine and Surgery · doi:10.1177/1098612x211036793 · Cited by 22 · see citing works

Allergenic Activity of Individual Cat Allergen Molecules

Trifonova, D., Curin, M., Riabova, K. A., Васильевна, К. А., Keller, W., Grönlund, H., Käck, U., Konradsen, J. R., van Hage, M., Karaulov, A. V., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242316729 · Cited by 22 · see citing works

Novel vaccines for allergen-specific immunotherapy

Akinfenwa, O., Rodríguez-Domínguez, A., Vrtala, S., Valenta, R., & Campana, R. (2020) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/aci.0000000000000706 · Cited by 22 · see citing works

Low‐affinity but high‐avidity interactions may offer an explanation for IgE‐mediated allergen cross‐reactivity

Chang, X., Zha, L., Wallimann, A., Mohsen, M. O., Krenger, P. S., Liu, X., Vogel, M., & Bachmann, M. F. (2021) · Allergy · doi:10.1111/all.14864 · Cited by 22 · see citing works

Molecular Allergen-Specific IgE Recognition Profiles and Cumulative Specific IgE Levels Associated with Phenotypes of Cat Allergy

Riabova, K., Karsonova, A. V., van Hage, M., Käck, U., Konradsen, J. R., Grönlund, H., Fomina, D., Beltyukov, E., Glazkova, P. A., Semenov, D. Y., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23136984 · Cited by 21 · see citing works

Allergenicity and Conformational Diversity of Allergens

Seidler, C. A., Zeindl, R., Fernández‐Quintero, M. L., Tollinger, M., & Liedl, K. R. (2024) · Allergies · doi:10.3390/allergies4010001 · Cited by 21 · see citing works

Allergen‐specific IgG show distinct patterns in persistent and transient food allergy

McKendry, R., Kwok, M., Hemmings, O., James, L. K., & Santos, A. F. (2021) · Pediatric Allergy and Immunology · doi:10.1111/pai.13567 · Cited by 21 · see citing works

Precision engineering for localization, validation, and modification of allergenic epitopes

Pomés, A., Smith, S. A., Chruszcz, M., Mueller, G. A., Brackett, N. F., & Chapman, M. D. (2024) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2023.12.017 · Cited by 23 · see citing works

Novel vaccines: Technology and development

Patil, S. U., & Shreffler, W. G. (2018) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2018.05.021 · Cited by 21 · see citing works

Nanobodies—Useful Tools for Allergy Treatment?

Flicker, S., Zettl, I., & Tillib, S. V. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.576255 · Cited by 21 · see citing works

REGN1908‐1909 monoclonal antibodies block Fel d 1 in cat allergic subjects: Translational pharmacokinetics and pharmacodynamics

Kamal, M. A., Dingman, R. K., Wang, C. Q. F., Lai, C., Rajadhyaksha, M., DeVeaux, M., Orengo, J. M., Radin, A. R., & Davis, J. D. (2021) · Clinical and Translational Science · doi:10.1111/cts.13112 · Cited by 20 · see citing works

B cells and the microbiota: a missing connection in food allergy

Campbell, E., Hesser, L. A., & Nagler‐Anderson, C. (2020) · Mucosal Immunology · doi:10.1038/s41385-020-00350-x · Cited by 20 · see citing works

IgE versus IgG and IgA : Differential roles of allergen‐specific antibodies in sensitization, tolerization, and treatment of allergies

Knol, E. F., & van Neerven, R. J. J. (2024) · Immunological Reviews · doi:10.1111/imr.13386 · Cited by 19 · see citing works

Biologics as novel therapeutics for the treatment of allergy: Challenges and opportunities

Atanasio, A., Orengo, J. M., Sleeman, M. A., & Stahl, N. (2022) · Frontiers in Allergy · doi:10.3389/falgy.2022.1019255 · Cited by 19 · see citing works

Persistence of the clinical effect of grass allergen peptide immunotherapy after the second and third grass pollen seasons

Ellis, A. K., Frankish, C. W., Armstrong, K., Steacy, L. M., Tenn, M. W., Pawsey, S., & Hafner, R. P. (2019) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2019.09.010 · Cited by 18 · see citing works

Immunotherapy in allergic diseases — improved understanding and innovation for enhanced effectiveness

Mitsias, D. I., Xepapadaki, P. V., Makris, M. P., & Papadopoulos, N. G. (2020) · Current Opinion in Immunology · doi:10.1016/j.coi.2020.02.005 · Cited by 18 · see citing works

Role of IgG4 Antibodies in Human Health and Disease

Shi, L., Xiong, P., Yang, M., Ardıçlı, Ö., Schneider, S. R., Funch, A. B., Kıykım, A. A., López, J.-F., Akdiş, C. A., & Akdiş, M. (2025) · Cells · doi:10.3390/cells14090639 · Cited by 21 · see citing works

The Role of Atopy in COPD and Asthma

Karakioulaki, M., Papakonstantinou, E., Goulas, A., & Stolz, D. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.674742 · Cited by 17 · see citing works

Research Advances in Mast Cell Biology and Their Translation Into Novel Therapies for Anaphylaxis

Dispenza, M. C., Metcalfe, D. D., & Olivera, A. (2023) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2023.03.015 · Cited by 18 · see citing works

Affinity matters for IgE ‐blocking activity of allergen‐specific antibodies

Strobl, M. R., Demir, H., Stadlmayr, G., Stracke, F., Hoelzl, R., Bohle, B., & Wozniak‐Knopp, G. (2023) · Allergy · doi:10.1111/all.15746 · Cited by 17 · see citing works

Advances and novel developments in molecular allergology

Üzülmez, Ö., Kalic, T., & Breiteneder, H. (2020) · Allergy · doi:10.1111/all.14579 · Cited by 17 · see citing works

IgE in the Pathogenesis of SLE: From Pathogenic Role to Therapeutic Target

Lamri, Y., & Charles, N. (2020) · Antibodies · doi:10.3390/antib9040069 · Cited by 17 · see citing works

Versatile Application of Nanobodies for Food Allergen Detection and Allergy Immunotherapy

Hu, Y., Wang, Y., Lin, J., Wu, S., Muyldermans, S., & Wang, S. (2022) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.2c03324 · Cited by 17 · see citing works

On the role of antibody affinity and avidity in the IgE ‐mediated allergic response

Bachmann, M. F., Krenger, P. S., Mohsen, M. O., Kramer, M. F., Starchenka, S., Whitehead, P., Vogel, M., & Heath, M. D. (2024) · Allergy · doi:10.1111/all.16248 · Cited by 16 · see citing works

Streamlining basophil activation testing to enable assay miniaturization and automation of sample preparation

Arif‐Lusson, R., Agabriel, C., Carsin, A., Cabon-Boudard, I., Sénéchal, H., Poncet, P., Vitte, J., & Busnel, J. (2020) · Journal of Immunological Methods · doi:10.1016/j.jim.2020.112793 · Cited by 16 · see citing works

Review: The Nose as a Route for Therapy. Part 2 Immunotherapy

Padayachee, Y., Flicker, S., Linton, S., Cafferkey, J., Kon, O. M., Johnston, S. L., Ellis, A. K., Desrosiers, M. Y., Turner, P., Valenta, R., et al. (2021) · Frontiers in Allergy · doi:10.3389/falgy.2021.668781 · Cited by 16 · see citing works

Isolation of nanobodies with potential to reduce patients' IgE binding to Bet v 1

Zettl, I., Ivanova, T. I., Strobl, M. R., Weichwald, C., Goryainova, O. S., Khan, E., Rutovskaya, M. V., Focke‐Tejkl, M., Drescher, A., Bohle, B., et al. (2021) · Allergy · doi:10.1111/all.15191 · Cited by 16 · see citing works

Recombinant PreS‐fusion protein vaccine for birch pollen and apple allergy

Khaitov, M. R., Shilovskiy, I. P., Valenta, R., Weber, M., Викторович, К. А., Tulaeva, I., Gattinger, P., van Hage, M., Höfer, G., Konradsen, J. R., et al. (2023) · Allergy · doi:10.1111/all.15919 · Cited by 15 · see citing works

Bioengineering of Virus-like Particles for the Prevention or Treatment of Allergic Diseases

Pechsrichuang, P., Namwongnao, S., & Jacquet, A. (2020) · Allergy Asthma and Immunology Research · doi:10.4168/aair.2021.13.1.23 · Cited by 15 · see citing works

Fel d1 Blocking Antibodies: A Novel Method to Reduce IgE-Mediated Allergy to Cats

Satyaraj, E., Sun, P., & Sherrill, S. (2021) · Journal of Immunology Research · doi:10.1155/2021/5545173 · Cited by 17 · see citing works

Mechanisms of allergen-specific desensitization

Uermösi, C., Beerli, R. R., Bauer, M., Manolova, V., Dietmeier, K., Buser, R. B., Kündig, T. M., Saudan, P., & Bachmann, M. F. (2010) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.05.040 · Cited by 99 · see citing works

Fel d 1-Specific IgG Antibodies Induced by Natural Exposure Have Blocking Activity in Skin Tests

Witteman, A. M., Stapel, S. O., Sjamsoedin, D. H. S., Jansen, H. M., Aalberse, R. C., & van der Zee, J. S. (2009) · International Archives of Allergy and Immunology · doi:10.1159/000237265 · Cited by 40 · see citing works

On the role of allergen-specific IgG subclasses for blocking human basophil activationPreprint

Vogel, M., Thoms, F., Augusto, G. S., & Bachmann, M. F. (2024) · doi:10.22541/au.170671012.27525086/v1

Targeting birch allergy with monoclonal IgG antibodies that bind allergen and prevent IgE effector cell activation

Atanasio, A., Franklin, M. C., Ben, L., Badithe, A., Bautista, J., Kamat, V., Hernandez, A. R., Olson, W. C., Murphy, A. J., Sleeman, M. A., et al. (2020) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2019.12.719 · Cited by 1 · see citing works